Home   |   Back to Category

Abstract "APPARENT EFFICACY AND SAFETY OF LOW DOSE NALTREXONE IN AUSTRALIAN PATIENTS WITH ACTIVE CROHN’S DISEASE"

Abstract Details

Title:
APPARENT EFFICACY AND SAFETY OF LOW DOSE NALTREXONE IN AUSTRALIAN PATIENTS WITH ACTIVE CROHN’S DISEASE
Author Name:
Belinda Jackson
Author Organisation:
Alfred Health
Summary/Description:
The aim is to examine local experience with low dose naltrexone (LDN) on disease activity and adverse events in patients with Crohn’s disease.

As per previous reports, LDN appears to be efficacious in a proportion of Australian patients with Crohn’s disease, particularly in those who were not taking immunomodulators. As a relatively inexpensive and well tolerated therapy, it may be a useful alternative treatment option to conventional immunomodulator therapy in active Crohn’s disease.
Category:
IBD Clinical
Presentation Type:
Poster

Abstract Download

File:
lindyjackson_222_20130611055027.docx

Co-Authors

Total Co-Authors added: 6

Name:
Belinda Jackson 
Organisation:
Alfred Health 
Name:
Diana Lewis 
Organisation:
Eastern Health 
Name:
Beswick Lauren 
Organisation:
Alfred Health 
Name:
Daniel Van Langenberg 
Organisation:
Eastern Health 
Name:
Miles Sparrow 
Organisation:
Alfred Health 
Name:
Peter Gibson 
Organisation:
Alfred Health